Ristl Robin, Urach Susanne, Rosenkranz Gerd, Posch Martin
a Center for Medical Statistics, Informatics, and Intelligent Systems , Medical University of Vienna , Vienna , Austria.
J Biopharm Stat. 2019;29(1):1-29. doi: 10.1080/10543406.2018.1489402. Epub 2018 Jul 9.
While current guidelines generally recommend single endpoints for primary analyses of confirmatory clinical trials, it is recognized that certain settings require inference on multiple endpoints for comprehensive conclusions on treatment effects. Furthermore, combining treatment effect estimates from several outcome measures can increase the statistical power of tests. Such an efficient use of resources is of special relevance for trials in small populations. This paper reviews approaches based on a combination of test statistics or measurements across endpoints as well as multiple testing procedures that allow for confirmatory conclusions on individual endpoints. We especially focus on feasibility in trials with small sample sizes and do not solely rely on asymptotic considerations. A systematic literature search in the Scopus database, supplemented by a manual search, was performed to identify research papers on analysis methods for multiple endpoints with relevance to small populations. The identified methods were grouped into approaches that combine endpoints into a single measure to increase the power of statistical tests and methods to investigate differential treatment effects in several individual endpoints by multiple testing.
虽然当前指南通常建议在确证性临床试验的主要分析中采用单一终点,但人们认识到,在某些情况下,需要对多个终点进行推断,以便全面得出治疗效果的结论。此外,综合几种结局指标的治疗效果估计值可以提高检验的统计功效。这种对资源的有效利用对于小样本量的试验尤为重要。本文回顾了基于跨终点的检验统计量或测量值组合的方法以及允许多个终点得出确证性结论的多重检验程序。我们特别关注小样本量试验中的可行性,并且不仅仅依赖渐近性考虑。我们在Scopus数据库中进行了系统的文献检索,并辅以人工检索,以识别与小样本量相关的多个终点分析方法的研究论文。所识别的方法被分为两类:一类是将终点合并为单一指标以提高统计检验功效的方法,另一类是通过多重检验研究几个个体终点中差异治疗效果的方法。